Search Results - "Pöllabauer, Eva Maria"

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial by Wressnigg, Nina, PhD, Pöllabauer, Eva-Maria, MD, Aichinger, Gerald, MD, Portsmouth, Daniel, PhD, Löw-Baselli, Alexandra, PhD, Fritsch, Sandor, PhD, Livey, Ian, PhD, Crowe, Brian A, PhD, Schwendinger, Michael, PhD, Brühl, Peter, PhD, Pilz, Andreas, PhD, Dvorak, Thomas, PhD, Singer, Julia, PhD, Firth, Clair, MSc, Luft, Benjamin, Prof, Schmitt, Bernhard, MD, Zeitlinger, Markus, MD, Müller, Markus, Prof, Kollaritsch, Herwig, Prof, Paulke-Korinek, Maria, MD, Esen, Meral, MD, Kremsner, Peter G, Prof, Ehrlich, Hartmut J, MD, Barrett, P Noel, Dr

“…Summary Background Lyme borreliosis is caused by Borrelia burgdorferi sensu stricto in the USA and by several Borrelia species in Europe and Asia, but no human…”
Get full text

Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines by Beck, Yvonne, Fritz, Richard, Orlinger, Klaus, Kiermayr, Stefan, Ilk, Reinhard, Portsmouth, Daniel, Pöllabauer, Eva-Maria, Löw-Baselli, Alexandra, Hessel, Annett, Kölch, Doris, Howard, M Keith, Barrett, P Noel, Kreil, Thomas R

“…Studies evaluating the immunogenicity of two pediatric tick-borne encephalitis virus (TBEV) vaccines have reported contradictory results. These vaccines are…”
Get full text

A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture by Ehrlich, Hartmut J, Müller, Markus, Oh, Helen M.L, Tambyah, Paul A, Joukhadar, Christian, Montomoli, Emanuele, Fisher, Dale, Berezuk, Greg, Fritsch, Sandor, Löw-Baselli, Alexandra, Vartian, Nina, Bobrovsky, Roman, Pavlova, Borislava G, Pöllabauer, Eva Maria, Kistner, Otfried, Barrett, P. Noel

“…There is a need for a vaccine against avian influenza (H5N1). In this initial study, the administration of two doses of a whole-virus H5N1 vaccine derived from…”
Get full text

A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato by Wressnigg, Nina, Barrett, P Noel, Pöllabauer, Eva-Maria, O'Rourke, Maria, Portsmouth, Daniel, Schwendinger, Michael G, Crowe, Brian A, Livey, Ian, Dvorak, Thomas, Schmitt, Bernhard, Zeitlinger, Markus, Kollaritsch, Herwig, Esen, Meral, Kremsner, Peter G, Jelinek, Tomas, Aschoff, Roland, Weisser, Roland, Naudts, Ingomar F K, Aichinger, Gerald

“…Lyme borreliosis (LB) patients who recover, as well as previously infected asymptomatic individuals, remain vulnerable to reinfection with Borrelia burgdorferi…”
Get full text

A Cell Culture (Vero)–Derived H5N1 Whole-Virus Vaccine Induces Cross-Reactive Memory Responses by Ehrlich, Hartmut J., Müller, Markus, Fritsch, Sandor, Zeitlinger, Markus, Berezuk, Greg, Löw-Baselli, Alexandra, van der Velden, Maikel V. W., Pöllabauer, Eva Maria, Maritsch, Friedrich, Pavlova, Borislava G., Tambyah, Paul A., Oh, Helen M. L., Montomoli, Emanuele, Kistner, Otfried, Noel Barrett, P.

“…Novel strategies are required to provide rapid vaccine coverage in the event of an influenza pandemic. A phase I/II dose finding/formulation study was…”
Get full text

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior by Prymula, Roman, Pöllabauer, Eva Maria, Pavlova, Borislava G., Löw-Baselli, Alexandra, Fritsch, Sandor, Angermayr, Rudolf, Geisberger, Alexander, Barrett, P. Noel, Ehrlich, Hartmut J.

“…Tick-borne encephalitis (TBE) vaccination strategies to induce optimal seroprotection in children are under constant evaluation. This multi-center, randomized,…”
Get full text

Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine: A Meta-Analysis of Immunogenicity, Safety and Posology by Pöllabauer, Eva Maria, Petermann, Robert, Ehrlich, Hartmut J.

“…A conjugate vaccine comprised of de-O-acetylated group C meningococcal polysaccharide coupled to tetanus toxoid (GCMP-TT) has been licensed in 32 countries and…”
Get full text

Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population by van der Velden, Maikel V. W., Fritz, Richard, Pöllabauer, Eva Maria, Portsmouth, Daniel, Howard, M. Keith, Kreil, Thomas R., Dvorak, Thomas, Fritsch, Sandor, Vesikari, Timo, Diez-Domingo, Javier, Richmond, Peter, Lee, Bee Wah, Kistner, Otffried, Ehrlich, Hartmut J., Barrett, P. Noel, Aichinger, Gerald

“…Background. Children are highly vulnerable to infection with novel influenza viruses. It is essential to develop candidate pandemic influenza vaccines that are…”
Get full text

The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants by Pöllabauer, Eva Maria, Petermann, Robert, Ehrlich, Hartmut J

“…Abstract Continuing additions of new vaccines to routine infant vaccination schedules have prompted concerns about potential interactions between vaccine…”
Get full text

IgE production after antigen-specific and cognate activation of HLA-DPw4-restricted T-cell clones, by 78% of randomly selected B-cell donors by Baselmans, Paul J, Pöllabauer, Eva-Maria, van Reijsen, Frank C, Heystek, Heleen C, Hren, Andrea, Stumptner, Pamela, Tilanus, Marcel G.J, Vooijs, Wim C, Mudde, Geert C

“…The frequency of expression of the MHC class II antigen, HLA-DPw4, in the caucasoid population is approximately 78%, and is unmatched by phenotypic frequencies…”
Get full text

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming by van der Velden, Maikel V.W, Aichinger, Gerald, Pöllabauer, Eva Maria, Löw-Baselli, Alexandra, Fritsch, Sandor, Benamara, Karima, Kistner, Otfried, Müller, Markus, Zeitlinger, Markus, Kollaritsch, Herwig, Vesikari, Timo, Ehrlich, Hartmut J, Barrett, P. Noel

“…Highlights ► Non-adjuvanted whole-virus H5N1 vaccine induces long-lasting memory response. ► Consistently strong booster responses following different…”
Get full text

Comparison of immunogenicity and safety between two paediatric TBE vaccines by Pöllabauer, Eva Maria, Pavlova, Borislava G, Löw-Baselli, Alexandra, Fritsch, Sandor, Prymula, Roman, Angermayr, Rudolf, Draxler, Wolfgang, Firth, Clair, Bosman, Jael, Valenta, Barbara, Harmacek, Peter, Maritsch, Friedrich, Barrett, P. Noel, Ehrlich, Hartmut J

“…Abstract TBE vaccination strategies capable of inducing strong paediatric immunogenicity and acceptable reactogenicity are still under evaluation. This…”
Get full text

Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine by Pöllabauer, Eva Maria, Fritsch, Sandor, Pavlova, Borislava G, Löw-Baselli, Alexandra, Firth, Clair, Koska, Manuela, Maritsch, Friedrich, Barrett, P. Noel, Ehrlich, Hartmut J

“…Abstract Two dose-finding studies and one open label safety study with a paediatric FSME-IMMUN® formulation were conducted in children and adolescents aged…”
Get full text